BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27816801)

  • 1. Medical cannabis and mental health: A guided systematic review.
    Walsh Z; Gonzalez R; Crosby K; S Thiessen M; Carroll C; Bonn-Miller MO
    Clin Psychol Rev; 2017 Feb; 51():15-29. PubMed ID: 27816801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
    Sznitman SR; Zolotov Y
    Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada.
    Capler R; Walsh Z; Crosby K; Belle-Isle L; Holtzman S; Lucas P; Callaway R
    Int J Drug Policy; 2017 Sep; 47():1-8. PubMed ID: 28667878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to access for Canadians who use cannabis for therapeutic purposes.
    Belle-Isle L; Walsh Z; Callaway R; Lucas P; Capler R; Kay R; Holtzman S
    Int J Drug Policy; 2014 Jul; 25(4):691-9. PubMed ID: 24947993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis education needs assessment among Canadian physicians-in-training.
    St Pierre M; Matthews L; Walsh Z
    Complement Ther Med; 2020 Mar; 49():102328. PubMed ID: 32147035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage.
    Sznitman SR; Lewis N
    Int J Drug Policy; 2015 May; 26(5):446-52. PubMed ID: 25661483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.
    Wolfe D; Corace K; Butler C; Rice D; Skidmore B; Patel Y; Thayaparan P; Michaud A; Hamel C; Smith A; Garber G; Porath A; Conn D; Willows M; Abramovici H; Thavorn K; Kanji S; Hutton B
    PLoS One; 2023; 18(2):e0281826. PubMed ID: 36800328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming primary care providers to engage in evidence-based discussions about cannabis with patients.
    Kansagara D; Becker WC; Ayers C; Tetrault JM
    Addict Sci Clin Pract; 2019 Dec; 14(1):42. PubMed ID: 31787111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
    Turna J; Patterson B; Van Ameringen M
    Depress Anxiety; 2017 Nov; 34(11):1006-1017. PubMed ID: 28636769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of 'medical cannabis' and mental health: a clinical perspective.
    Newton-Howes G
    Br J Clin Pharmacol; 2018 Nov; 84(11):2499-2501. PubMed ID: 29926471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and long-term effects of cannabis use: a review.
    Karila L; Roux P; Rolland B; Benyamina A; Reynaud M; Aubin HJ; Lançon C
    Curr Pharm Des; 2014; 20(25):4112-8. PubMed ID: 24001294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical use of cannabis: an addiction medicine perspective.
    Cook J; Lloyd-Jones DM; Ogden E; Bonomo Y
    Intern Med J; 2015 Jun; 45(6):677-80. PubMed ID: 26059881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes.
    Balneaves LG; Alraja A; Ziemianski D; McCuaig F; Ware M
    Cannabis Cannabinoid Res; 2018; 3(1):66-73. PubMed ID: 29588917
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review.
    Hudson A; Hudson P
    Clin Gerontol; 2021; 44(1):3-15. PubMed ID: 32862795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cannabis--Position Paper of the German Respiratory Society (DGP)].
    Kreuter M; Nowak D; Rüther T; Hoch E; Thomasius R; Vogelberg C; Brockstedt M; Hellmann A; Gohlke H; Jany B; Loddenkemper R
    Pneumologie; 2016 Feb; 70(2):87-97. PubMed ID: 26935046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.
    Hadland SE; Knight JR; Harris SK
    J Dev Behav Pediatr; 2015; 36(2):115-23. PubMed ID: 25650954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis in medicine: a national educational needs assessment among Canadian physicians.
    Ziemianski D; Capler R; Tekanoff R; Lacasse A; Luconi F; Ware MA
    BMC Med Educ; 2015 Mar; 15():52. PubMed ID: 25888752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.